Status: Not yet recruiting
IPSC-CMs Combined with LVAD or CABG for the Treatment of Heart Failure
This clinical trial investigates the safety, feasibility, and therapeutic potential of a combined approach using HiCM-188 cardiomyocyte injection delivered intramyocardially alongside either LVAD implantation or CABG surgery in patients with advanced ischemic heart failure.
Participants needed: 40
Trial details
Phase: Phase 1, Phase 2Age: 35-75Biological sex: AllType: InterventionalSponsor: HELP Therapeutics Co., Ltd.Updated: Mar 14, 2025Locations: 1
Eligibility criteria
Male or female aged 35-75 years (inclusive) at the time of signing the informed... [+10]
History of pacemaker, implantable cardioverter-defibrillator (ICD), or cardiac r... [+17]